Wednesday, April 16, 2025
HomeTagsCUE-501 product

CUE-501 product

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases

Boehringer Ingelheim and Cue Biopharma, announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product candidate, a differentiated B...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics